|
AU5778601A
|
|
Synthetic matrix metalloprotease inhibitors and uses thereof
|
|
WO9929705A2
|
|
Sialyl lewis x and sialyl lewis a glycomimetics
|
|
WO9929706A2
|
|
DISALICYLATE ANALOG BASED SIALYL LEWISx MIMETICS
|
|
AU8311898A
|
|
Synthetic matrix metalloprotease inhibitors and uses thereof
|
|
EP0888369A1
|
|
Sialyl lewis x mimetics containing flavanoid backbones
|
|
WO9718222A2
|
|
Novel oligosaccharide glycosides having mammalian immunosuppressive and tolerogenic properties
|
|
US5654412A
|
|
Processes for the synthesis of sialyl Lewisx compounds
|
|
EP0828729A1
|
|
Collection of activated glycoside compounds and their biological use
|
|
US5837689A
|
|
Sialyl lewis-x mimetics containing naphthyl backbones
|
|
US5789385A
|
|
Sialyl Lewisx mimetics containing phenyl backbones
|
|
AU4364196A
|
|
Processes for the synthesis of 3'-substituted lewisxlewisx compounds
|
|
US5695738A
|
|
Steroidal C-glycosides
|
|
US5679321A
|
|
Sialic acid/fucose based medicaments
|
|
US5849709A
|
|
Saccharopeptides and derivatives thereof
|
|
EP0758247A1
|
|
O-desulfated heparin derivatives, methods of making and uses thereof
|
|
US5696100A
|
|
Method for controlling O-desulfation of heparin and compositions produced thereby
|
|
AU8013694A
|
|
Highly sulfated maltooligosaccharides with heparin-like properties
|
|
WO9510296A1
|
|
A library of glyco-peptides useful for identification of cell adhesion inhibitors
|
|
US5739115A
|
|
Sulfated maltooligosaccharides with heparin-like properties
|
|
US5658880A
|
|
Sialic acid/fucose based medicaments
|
